Dynamic Contrast-Enhanced Imaging

Dynamic Contrast-Enhanced Imaging

Dynamic Contrast-Enhanced Imaging

On this page

DCEI Basics - Perfusion Peeking

  • Dynamic Contrast-Enhanced Imaging (DCEI) non-invasively assesses tissue perfusion and microvasculature.
  • Involves rapid, sequential imaging after intravenous administration of a contrast agent (e.g., Gadolinium-based for MRI).
  • Tracks contrast agent (CA) passage:
    • Inflow into tissue
    • Distribution within interstitial space
    • Washout from tissue
  • Signal intensity changes over time are converted into CA concentration curves, reflecting tissue hemodynamics.
  • Key insights:
    • Evaluates blood flow, vessel density, and permeability.
  • Parameters like $K^{trans}$ (volume transfer constant) reflect capillary permeability. DCE-MRI contrast agent kinetics curve types

⭐ DCE-MRI provides quantitative assessment of tumor angiogenesis and response to therapy.

Technique & Contrast - The How‑To & Hue

  • Baseline: Pre-contrast T1-weighted (T1W) images, often fat-suppressed.
  • Contrast: Rapid IV bolus of Gadolinium-Based Contrast Agent (GBCA).
    • Dose: 0.1 mmol/kg.
    • Type: Extracellular (e.g., Gadobutrol).
  • Dynamic Scan: Fast, serial T1W sequences post-contrast.
    • High temporal resolution (e.g., <15s/acquisition) is vital.
  • Analysis:
    • Time-intensity curves (TICs) generated.
    • Pharmacokinetic models (e.g., Tofts) quantify:
      • $K^{trans}$ (volume transfer constant)
      • $v_e$ (EES volume fraction)
      • $k_{ep}$ (rate constant $K^{trans}/v_e$)

DCE-MRI time-intensity curves: benign vs malignant

⭐ High temporal resolution is crucial for accurate pharmacokinetic modeling in DCE imaging.

PK Models & Parameters - Numbers Game

  • Core Idea: Quantify tissue perfusion & capillary permeability using contrast agent kinetics.
  • Common Models:
    • Tofts Model: Simpler; uses $K^{trans}$, $v_e$. Ignores $v_p$.
    • Extended Tofts Model (ETM): More comprehensive; uses $K^{trans}$, $v_e$, $v_p$.
  • Key Parameters (Units: min⁻¹ or fraction):
    • $K^{trans}$ (Volume Transfer Constant):
      • Capillary permeability & blood flow. ↑ in tumors.
      • Typical tumor range: 0.1-0.5 min⁻¹.
    • $v_e$ (EES Volume Fraction):
      • Extracellular extravascular space.
      • Typical range: 0.1-0.6.
    • $v_p$ (Plasma Volume Fraction):
      • Blood plasma volume.
      • Typical range: 0.01-0.1.
    • $k_{ep}$ (Rate Constant): $k_{ep} = K^{trans} / v_e$.
      • Washout from EES.

⭐ $K^{trans}$ is a key parameter reflecting endothelial permeability and blood flow, often elevated in tumors.

image

Clinical Uses & Caveats - Scan Savvy

  • Oncology Focus:
    • Tumor: Detection, characterization, staging.
    • Treatment Monitoring: Especially anti-angiogenic therapy response.

    ⭐ In oncology, a decrease in $K^{trans}$ post-therapy often indicates a positive response to anti-angiogenic treatment.

  • Key Applications:
    • Brain: Ischemia, tumors, MS.
    • Breast: Lesion workup.
    • Prostate: Cancer detection.
    • MSK: Arthritis, tumors. DCE-MRI tumor perfusion maps (Ktrans)
  • Important Caveats:
    • ⚠️ Contrast: Allergy/NSF risk (check eGFR for GBCAs).
    • Motion artifacts.
    • Complex analysis; software & expertise needed.
    • Protocol variability.
    • Patient factors: Renal function, pregnancy.

High‑Yield Points - ⚡ Biggest Takeaways

  • DCE-MRI assesses tissue microvasculature, including perfusion and capillary permeability, using T1-weighted imaging post-gadolinium.
  • Key parameters: Ktrans (volume transfer constant), Ve (extravascular extracellular space fraction), Vp (plasma volume fraction).
  • Ktrans reflects capillary permeability and blood flow; typically elevated in malignant tumors.
  • Pharmacokinetic models (e.g., Tofts) analyze signal intensity-time curves to derive parameters.
  • Applications: tumor grading, differentiating benign vs. malignant, and monitoring treatment response.
  • Accurate Arterial Input Function (AIF) measurement requires high temporal resolution during acquisition.
  • Primarily used in oncology for tumor assessment and evaluating anti-angiogenic therapy effects.

Practice Questions: Dynamic Contrast-Enhanced Imaging

Test your understanding with these related questions

Volume of distribution of a drug is 500 ml and target concentration of drug in blood is 5 g/L. 20% of administered drug is reached to systemic circulation. What will be the loading dose of that drug -

1 of 5

Flashcards: Dynamic Contrast-Enhanced Imaging

1/6

The application of MR to imaging was first done by _____

TAP TO REVEAL ANSWER

The application of MR to imaging was first done by _____

Paul Lauterbur.

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial